What’s Preoccupying the New FDA Diagnostics Chief? Focus on Transitions, the LDT Rule, and Cybersecurity | Exclusive Article from FDA Today

Courtney Lias has taken on the role of the permanent Director of the Office of Health Technology 7 (OHT7) at the Center for Devices and Radiological Health (CDRH), following her tenure as Acting Director after Tim Stenzel’s departure at the end of 2023. Lias officially announced her new position during a conference in Washington D.C. this week. Her leadership arrives at a pivotal time for OHT7, as the office is deeply involved in significant regulatory reform initiatives. The CDRH itself is structured into seven main offices, including a “super office” named the Office of Product Evaluation and Quality (OPEQ), indicating the critical administrative and regulatory frameworks within which these offices operate.
#Whats #FDAs #Diagnostics #Chiefs #mind #Transitions #LDT #rule #cybersecurity #Exclusive #FDA #Today #Article